Cite
HARVARD Citation
Mahmoud, R. et al. (2021). Continuation of Anti-TNF in Patients With Ulcerative Colitis in Remission Is Not Cost-effective Compared With Treatment Withdrawal: A Markov Model. Journal of Crohn's and colitis. pp. 709-718. [Online].